Showing results (281-290 of 330) with videos related to

Sort By:
Pageof 33
Neuropsychopharmacology Reports|February 6, 2020
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophreniaNoriko Kudo, Hidenaga Yamamori, Tamaki Ishima, et al.
The International Journal of Neuropsychopharmacology|March 13, 2018
Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with SchizophreniaNoriko Kudo, Hidenaga Yamamori, Tamaki Ishima, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 28, 2009
Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese populationTomo Okochi, Taro Kishi, Masashi Ikeda, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|April 6, 2019
Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patientsTeruhiko Higuchi, Jun Ishigooka, Masaomi Iyo, et al.
Psychiatry Research|July 15, 2015
Decreased levels of serum oxytocin in pediatric patients with Attention Deficit/Hyperactivity DisorderTsuyoshi Sasaki, Kenji Hashimoto, Yasunori Oda, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 22, 2007
The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorderYukitaka Morita, Hiroshi Ujike, Yuji Tanaka, et al.
Biological Psychiatry|June 9, 2007
The dysbindin gene (DTNBP1) is associated with methamphetamine psychosisMakiko Kishimoto, Hiroshi Ujike, Yasuko Motohashi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 24, 2009
A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosisTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
Pageof 33